CURRICULUM VITAE - University of Maryland School of …



CURRICULUM VITAE

HOWARD AARON IAN KADER, M.D.

Assistant Professor

Director, Pediatric Inflammatory Bowel Disease Center

Department of Pediatrics

The University of Maryland Hospital for Children

The University of Maryland School of Medicine

November, 2016

Contact Information: Department of Pediatrics

The University of Maryland School of Medicine

Division of Pediatric Gastroenterology & Nutrition

The University of Maryland Hospital for Children

22 South Greene Street, Rm N5W68

Baltimore, MD 21201-1595

Ph: 410-328-0812

Fax: 410-320-1072

hkader@peds.umaryland.edu

EDUCATION:

1983-87 B.A. cum laude, 5/15/1987, Washington University in St. Louis, MO

Major: History & Biology

Thesis “Oil and the Role of the Netherland East Indies in the

Japanese-American Far Eastern Crisis 1938-1941”

Thesis Advisor: Henry W. Berger

1988-92 M.D. 5/9/1992 University of Nebraska College of Medicine, Omaha, NE

POST GRADUATE EDUCATION AND TRAINING:

88. Unclassified Student Status in the Departments of Pediatrics and Anatomy

University of Nebraska College of Medicine, Omaha

93. Intern in General Surgery

Washington Hospital Center, Washington, D.C.

94. Intern in Pediatrics, Creighton-Nebraska Universities Health Foundation Joint

Pediatric Residency Program

University of Nebraska Medical Center, Omaha

96. Resident in Pediatrics, Creighton-Nebraska Universities Health Foundation Joint

Pediatric Residency Program

University of Nebraska Medical Center, Omaha

97. Clinical Fellow in Pediatric Gastroenterology and Nutrition

The Children’s Hospital of Philadelphia, Philadelphia

1997-99 Research Fellow in Pediatric Gastroenterology and Nutrition

The Children’s Hospital of Philadelphia, Philadelphia

CERTIFICATIONS:

1993 National Board of Medical Examiners

1996 American Board of Pediatrics

1999. American Board of Pediatrics Subspecialty Pediatric Gastroenterology & Nutrition

2004. American Board of Pediatrics – Recertification 2004-2010

2007. American Board of Pediatrics Subspecialty Pediatric Gastroenterology & Nutrition –

Recertification 2007-2013

2010. American Board of Pediatrics - enrollment in Maintenance of Certification (MOC)

10/15/10 - General Pediatrics - Meeting MOC Requirements & Pediatric

Gastroenterology - Meeting MOC Requirements

MEDICAL LICENSURES:

1993 - Nebraska (inactive status)

1995 - Commonwealth of Pennsylvania (inactive status)

1997 - New Jersey (inactive status)

1999 - North Carolina (inactive status)

2002 - Maryland

EMPLOYMENT HISTORY:

ACADEMIC APPOINTMENTS:

1996 - 1999 Instructor in Pediatrics, Department of Pediatrics

University of Pennsylvania School of Medicine

1999 - 2002 Assistant Professor of Pediatrics, Department of Pediatrics

Duke University School of Medicine

2009 - Assistant Professor of Pediatrics, Department of Pediatrics

University of Maryland School of Medicine

OTHER EMPLOYMENT:

1987- 1988 Cytogenetic Technologist

Hattie B. Monroe Center for Human Genetics

University of Nebraska Medical Center, Omaha

HOSPITAL AND ADMINISTRATIVE APPOINTMENTS:

1998 - 1999 Associate, Department of Pediatrics

West Jersey Hospital - Voorhees

West Jersey Health System, NJ

1998 – 1999 Assistant, General Pediatrics

The Children’s Hospital of Philadelphia

1999 - 2002 Assistant, Department of Pediatrics

Duke University Medical Center

1999 - 2001 Consultant, Department of Pediatrics

Southern Regional Area Health Education Center

Cape Fear Valley Medical Center

2000 - 2002 Associate, Department of Medicine

Raleigh Community Hospital

Duke University Health System

2002 - 2009 Member of the Active Staff

Department of Pediatrics

Sinai Hospital of Baltimore - 8/18/2002

2004 - 2009 Upper Chesapeake Medical Center

Associate, Department of Pediatrics - 5/27/2009

2004 - 2009 Greater Baltimore Medical Center

Associate Staff, Department of Pediatrics – 6/30/2009

2009 - Assistant Professor, Department of Pediatrics

University of Maryland School of Medicine

University of Maryland Medical Center 7/1/2009 -

2010 - Mount Washington Pediatric Hospital

Consultant Staff Without Admitting Privileges

Pediatric Gastroenterology, 3/17/10

2012- National Institutes of Health

Level 1 (NACI) position

Special Volunteer Appointment 6/27/2012 -

PROFESSIONAL SOCIETY MEMBERSHIPS:

National Societies:

1987 - 1988 Association of Cytogenetic Technologists (ACI)

1988 - 2000 American Medical Association

1993 - 2002 American Academy of Pediatrics

1996 - American Gastroenterology Association

1996 - North American Society of Pediatric Gastroenterology and Nutrition

1997 - 2002 Fellow of the American Academy of Pediatrics

1997 - Crohn’s and Colitis Foundation of America, Inc.

2012 - American College of Gastroenterology

Local Societies:

1988 - 1996 Nebraska Medical Association

1992 - 1993 Medical Society of the District of Columbia

1886 – 1998 New Jersey Chapter - American Medical Association

1999 - 2002 North Carolina Pediatric Society

2000 – 2001 Crohn’s and Colitis Foundation of America, North Carolina Chapter

2001 - 2002 Crohn’s and Colitis Foundation of America, Carolinas Chapter

2004 - Crohn’s and Colitis Foundation of America, Maryland & Southern Delaware

Chapter

HONORS and AWARDS:

1984 Dean’s List, Washington University in St. Louis

88. Phi Alpha Theta

2000. Who’s Who in the World, 18th Edition, 2001

2002 Crohn’s and Colitis Foundation of America, Carolinas Chapter

Premier Physician Recognition Award

2004 Guide to America’s Top Pediatricians, Consumers’ Research Council of America

2005 Guide to America’s Top Pediatricians, Consumers’ Research Council of America,

2nd edition

2007. Guide to America’s Top Gastroenterologists, 1st edition, 2007, Consumers’

Research Council of America,

2013 Doctors of Excellence

ADMINISTRATIVE SERVICE:

INSTITUTIONAL SERVICE:

ACADEMIC COMMITTEES AT SINAI HOSPITAL OF BALTIMORE:

2009. Scholarly Activity Committee, The Herman & Walter Samuelson Children’s

Hospital at Sinai

ACADEMIC COMMITTEES AT UNIVERSITY OF MARYLAND HOSPITAL FOR

CHILDREN:

2010 - Investigation Review Board UMMS Department Signatory for Pediatrics

2010 - Fellowship Scholarly Activity Oversight Committee, Univ of MD Sch of Med

2012 - Data Safety Management Committee – “Measures of Intestinal Permeability in

Univ of MD Sch of Med Preterm Neonates”

2016 - School of Medicine Council member – University of Maryland School of

Medicine

LOCAL AND NATIONAL SERVICE:

LOCAL STATE COMMITTEES:

2000 - 2001 Crohn’s and Colitis Foundation of America, North Carolina Chapter

Local Coordinating Committee – RTP Area

2001 - 2002 Crohn’s and Colitis Foundation of America, Carolinas Chapter – Local

Coordinating Committee – RTP Area

2004 - 2009 Crohn’s and Colitis Foundation of America, Maryland & Southern

Delaware Chapter – Medical Advisory Committee

NATIONAL COMMITTEES:

2002 Member, IBD Subcommittee , North American Society for Pediatric

Gastroenterology, Hepatology and Nutrition.

2010-2013 Member, IBD Committee, North American Society for Pediatric

Gastroenterology, Hepatology and Nutrition (10/10-10/13)

TEACHING SERVICE:

CLINICAL DUTIES:

1999. Attending Physician In-patient Services, Duke University Medical Center

2 residents, 2 interns, 2 jr. students

8 hours/day, 6 months/year

2000. Attending Physician In-patient Services, Duke University Medical Center

2 residents, 2 interns, 2 jr. students

8 hours/day, 4 months/year

2001. Attending Physician In-patient Services, Duke University Medical Center

2 residents, 2 interns, 2 jr. students

8 hours/day, 3 months/year

2002. Attending Physician In-patient Services, Duke University Medical Center

and The Herman & Walter Samuelson Children’s Hospital at Sinai

2 residents, 2 interns, 1-2 jr. students

8 hours/day, 4 months/year

2003-2004 Attending Physician In-patient Services, The Herman & Walter Samuelson

Children’s Hospital at Sinai

2 residents, 2 interns, 1-2 jr. students

8 hours/day, 4 months/year

2005-2008 Attending Physician In-patient Services, The Herman & Walter Samuelson

Children’s Hospital at Sinai

2 residents, 2 interns, 1-2 jr. students

8 hours/day, 3 months/year

2008. Attending Physician In-patient Services, The Herman & Walter Samuelson

Children’s Hospital at Sinai

2 residents, 2 interns, 1-2 jr. students

8 hours/day, 4 months/year

2009 Attending Physician In-patient Services, The University of Maryland Hospital for

Children

1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students

8 hours/day, 4 months/year

2010 Attending Physician In-patient Services, The University of Maryland Hospital for

Children

1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students

8 hours/day, 4 months/year

2011 Attending Physician In-patient Services, The University of Maryland Hospital for

Children

1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students

8 hours/day, 4 months/year

2012 Attending Physician In-patient Services, The University of Maryland Hospital for

Children

1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students

8 hours/day, 4 months/year

2013 Attending Physician In-patient Services, The University of Maryland Hospital

Children’s Hospital

1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students

8 hours/day, 4 months/year

2014 Attending Physician In-patient Services, The University of Maryland Hospital Children’s Hospital

1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students

8 hours/day, 4 months/year

2015 Attending Physician In-patient Services, The University of Maryland Hospital

Children’s Hospital

1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students

8 hours/day, 4 months/year

2016 Attending Physician In-patient Services, The University of Maryland Hospital

Children’s Hospital

1 GI Fellow, 2 residents, 2 interns, 1-2 jr. students

8 hours/day, 4 months/year

MENTORING ACTIVITIES:

2003-2006 1 resident, 1 hour/month Clinical Research Project: “A Single Center Retrospective

Study on the Post-Operative Use of 6-mercaptopurine and/or Infliximab for

Pediatric Patients with Crohn’s Disease”. (Presented, North American Society for

Pediatric Gastroenterology and Nutrition, Annual Meeting, October 2006, Orlanda,

FL)

2008-2009 1 resident, 1 hour/month Clinical Research Project: “Utilization of Proton Pump

Inhibitors to Treat Infantile GERD: Analysis of Appropriate Indications for Use,

Efficacy, and Tolerance”

2010 - 2013 1 Fellow, Fellow’s Research Project in Pediatric Gastroenterology involving IBD

2012 - 2013 1 Resident, Resident’s Research Project in Pediatric Gastroenterology on IBD

2013 - 2014 1 Resident, Resident’s Research Project in Pediatric Gastroenterology on IBD

2013 - 2016 1 Medical Student’s Research Project in Pediatric Gastroenterology on Short

Bowel Syndrome

2015 - 2016 1 Fellow, Fellow’s Research Project in Pediatric Gastroenterology involving IBD

RESIDENT/FELLOW CONFERENCES:

Duke University Medical Center, Durham, NC; Pediatric Resident Noon Conference

3/4/2002 “Inflammatory Bowel Disease”

Duke University Medical Center, Durham, NC; Pediatric Resident Noon Conference

3/6/2002 “Cytokines Profile and Therapy in Inflammatory Bowel Disease –

Biologics”

Duke University Medical Center, Durham, NC; Pediatric Resident Noon Conference

3/13/2002 “Upper GI Foreign Bodies”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon

Conference 5/6/2002 “Gastroesophageal Reflux Disease”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon

Conference 5/2003 “Upper GI Tract Foreign Bodies”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon

Conference 9/2003 “Pediatric IBD”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon

Conference 11/2003 “Pediatric IBD Medication/Management Part 1”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon

Conference 12/2003 “Pediatric IBD Medication/Management Part 2”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon

Conference 01/2006 “Pancreatitis in Childhood”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon

Conference 01/2007 “Pediatric Gastroesophageal Reflux Disease”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon

Conference 06/2007 “Total Parenteral Nutrition: The Hows and Whats To Do”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon

Conference 02/20/2008 “Pediatric Inflammatory Bowel Disease”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon

Conference 08/19/2008 “Total Parenteral Nutrition: The Hows and Whats To Do”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Resident Noon

Conference 03/12/2008 “Pediatric Inflammatory Bowel Disease”

University of Maryland Hospital for Children; Peds GI Fellow Conference 08/25/2009. “Anti-

TNF Medications in IBD”.

University of Maryland Hospital for Children; Peds GI Fellow Conference 09/17/2009. “Non-

Anti-TNF Medications in IBD”.

University of Maryland Hospital for Children; Pediatric Resident Noon Conference

02/17/2010. “Pediatric Gastroesophageal Reflux Disease”.

University of Maryland Hospital for Children; Peds GI Fellow Conference 06/04/2010.

Journal Club-Article Reviews.

University of Maryland Hospital for Children; Pediatric Resident Noon Conference

10/26/2010. “Medical Therapy Used in Pediatric Inflammatory Bowel Disease”.

University of Maryland Hospital for Children; Peds GI Fellow Conference 11/04/2010.

Journal Club-Article Reviews.

University of Maryland Hospital for Children; Pediatric Resident Noon Conference

10/14/2013. “Diagnosis and Management of GERD in Pediatric Patients”.

University of Maryland Hospital for Children; Pediatric Resident Noon Conference

3/9/2014. “Pediatric IBD”.

University of Maryland Hospital for Children; Pediatric Resident Noon Conference

10/26/2016. “Pediatric Inflammatory Bowel Disease”.

University of Maryland Hospital for Children; Pediatric Resident Noon Conference

10/28/2016. “Biologics In Inflammatory Bowel Disease”.

GRANT SUPPORT:

COMPLETED GRANTS:

1997 100% Effort

Principal Investigator

Efficacy of Intravenous Loading of Azathioprine in Children, Adolescents, and

Young Adults with Severe Inflammatory Bowel Disease

Junior Clinical Investigator Award (non-peer-reviewed)

The General Clinical Research Center, ($10,000 / one year)

The Children’s Hospital of Philadelphia, Philadelphia, PA

98. 100% Effort

Principal Investigator

Efficacy of Intravenous Loading of Azathioprine in Children, Adolescents, and

Young Adults with Severe Inflammatory Bowel Disease

Nutrition Center Pilot Project (non-peer-reviewed)

Howard Heinz Endowment, ($3,000 / one year)

The Children’s Hospital of Philadelphia, Philadelphia, PA

2000. 100% Effort

Principal Investigator

The Prevalence of Inherited Thrombotic Markers in Pediatric Patients with

Inflammatory Bowel Disease

Duke Children’s Miracle Network ($16,000 / one year) (non-peer-reviewed)

Duke University Medical Center, Durham, NC

SPONSORED LECTURES:

2002 - 2004 GERD lecture/speaker bureau for TAP Pharmaceuticals

2006 - 2009 GERD lecture/speaker bureau for TAP Pharmaceuticals

PUBLICATIONS:

Peer-reviewed journal articles:

1. Kader HA, Kaufman SS, Raynor SC, Young R, Vanderhoof J, Ruby EI, Mack DR. Introduction of

6-mercaptopurine in Crohn’s disease patients during the perioperative period: A

preliminary evaluation of recurrence of disease. J Pediatr Gastroenterol Nutr 1997;

25(1):93-97.

2. Kader HA, Ruchelli E, Maller ES. Langerhans’ cell histiocytosis presenting with stool retention

due to a perianal mass. J Pediatr Gastroenterol Nutr 1998; 26:226-228.

3. Kader HA, Baldassano RN, Harty MP, Nicotra JJ, von Allmen D, Finn L, Markowitz J, Carrier

M, Piccoli DA. A ruptured retrocecal appendicitis in an adolescent presenting as portal-

mesenteric thrombosis and pylephlebitis. J Pediatr Gastroenterol Nutr 1998; 27:584-588.

4. Kader HA, Piccoli DA, Jawad AF, McGowan KL, Maller ES. Single toxin detection is

inadequate to diagnose Clostridium difficile diarrhea in pediatric patients.

Gastroenterology 1998; 115(6):1329-1334.

5. Kader HA, Mascarenhas MR, Piccoli DA, Stouffer NO, Baldassano RN. Experiences of

6-mercaptopurine and azathioprine therapy in pediatric patients with severe ulcerative colitis.

J Pediatr Gastroenterol Nutr 1999; 28:54-58.

6. Kader HA, Telega GW, Wenner WJ, Rand EB, Maller ES, Baldassano RN. Normal thiopurine

methyltransferase levels do not eliminate 6-mercaptopurine or azathioprine toxicity in

children with inflammatory bowel disease. J Clin Gastro 2000; 30(4):409-413.

7. Kader HA, Mascarenhas MR, Verma R, Collins M, Ruchelli E, Baldassano RN. Colonic

Inflammation Found at Diagnosis of Juvenile Retention Polyps in Pediatric Patients.

Am J Gastroenterol 2000; 95(8):1990-1993.

8. Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR. “Prevalence of

Factor G1691A (Leiden), Prothrombin G20210A and Methylene Tetrahydrofolate

Reductase C677T Thrombophilic Mutations in Children with Inflammatory Bowel

Disease”. J. Pediatr Gastroenterol Nutr 2002; 35(5):629-635.

9. Kader HA, Bellah RD, Maller ES, Mamula P, Piccoli DA, Markowitz JE. The utility of

ultrasound site selection for pediatric percutaneous liver biopsy. J. Pediatr

Gastroenterol Nutr 2003; 36(3): 364-367.

10. Kader HA, Tchernev VT, Satyaraj E, Lejnine S, Kotler G, Kingsmore SF, Patel DD. Protein

Microarray Analysis of Disease Activity in Pediatric Inflammatory Bowel Disease

Demonstrates Elevated Serum PLGF, IL-7, TGF-(1 and IL-12p40 levels in Crohn’s

Disease and Ulcerative Colitis Patients in Remission versus Active Disease. Am. J.

Gastroenterol 2005; 100(2):414-423.

11. Colletti, RB, Baldassano, RN, Milov, DE, Margolis, PA, Bousvaros, A, Crandall, WV,

Crissinger, KD, D’Amico, MD, Day, AS, Denson, LE, Dubinsky M, Ebach, DR,

Hoffenberg, EJ, Kader, HA, Keljo, DJ, eibowitz, IA, Mamula, P, Pfefferkorn, MD,

Qureshi, MA for PIBDNet—the Pediatric IBD Network for Research and Improvement.

Variation in Care in Pediatric Crohn’s Disease. J. Pediatr Gastroenterol Nutr.

2009;49(3):297-303.

12. Ming-Hsi Wang, MD, PhD, Toshihiko Okazaki, MD, PhD, Subra Kugathasan, MD, Judy H.

Cho, MD, Kim L. Isaacs, MD, James D. Lewis, MD, Duane T. Smoot, MD, John F.

Valentine, MD, Howard A. Kader, MD, Jean G. Ford, MD, Mary L. Harris, MD, Maria

Oliva-Hemker, MD, Carmen Cuffari, MD, Michael S. Torbenson, MD, Richard H. Duerr,

MD, Mark Silverberg, MD, PhD, John D. Rioux, PhD, Kent D. Taylor, PhD, Geoffrey C.

Nguyen, MD, PhD, Yuqiong Wu, MD, Lisa W. Datta, MSc, Stanley Hooker, BS,

Themistocles Dassopoulos, MD, Rick A. Kittles, PhD Linda W.H. Kao, PhD, Steven R.

Brant, MD. Contribution of Higher Risk Genes and European Admixture to Crohn’s

Disease in African Americans. Inflammatory Bowel Disease Journal. 2012;18(12):2277-

2287. (published online 3/12/2012, DOI: 10.1002/ibd.22931).

13. Kader, HA, Martin, M, Twaddell WS, Drachenberg, CI, Jinadu LA. Periorbital Edema and

Abdominal Distension: Beyond Celiac Disease. Consultant For Pediatricians. 2013;

12(9):406-410.

14. DeZoeten, E. Mattei, P. Pasternak, B. Kramer, R. Kader, HA. Perianal Crohn's disease

Clinical report/Consensus statement for NASPGHAN. J. Pediatr Gastroenterol Nutr.

2013; 57(3):401-412.

Booth, Jayaum S, Toapanta, Franklin R. Salemo-Goncalves, Rosangela. Patil, Seema.

Kader, Howard. Safta, Anca. Czinn, Steve. Greenwald, Bruce. and Sztein, Marcelo B.,

Characterization and functional properties of gastric tissue-resident memory T cells from

Children, adults and the elderly. Front Immunol. 2014, (294):1-5.

15. Booth, JS, Salerno-Goncalves, R, Blanchard, TG, Patil, SA, Kader, HA, Safta, AM,

Morningstar,LM, Czinn, SJ, Greenwald, BD and Sztein MB. Mucosal Associated Invariant T

cells in the human gastric mucosa and blood: Role in Helicobacter pylori infection.

Front Immunol. 2015, 6:466

16. Chengrui Huang, Talin Haritunians, David T. Okou, David J. Cutler, Michael E. Zwick, Kent D.

Taylor, Lisa W. Datta, Joseph C. Maranville, Zhenqiu Liu, Shannon Ellis, Pankaj Chopra,

Jonathan S. Alexander, Robert N. Baldassano, Raymond K. Cross, Themistocles

Dassopoulos, Tanvi A. Dhere, Richard H. Duerr, John S. Hanson, Jason K. Hou, Sunny

Z. Hussain, Kim L. Isaacs, Kelly E. Kachelries, Howard Kader, Michael D. Kappelman,

Jeffrey Katz, Richard Kellermayer, Barbara S. Kirschner, John F. Kuemmerle, Archana

Kumar, John H. Kwon, Mark Lazarev, Peter Mannon, Dedrick E. Moulton, Bankole O.

Osuntokun, Ashish Patel, John D. Rioux, Jerome I. Rotter, Shehzad Saeed, Ellen J.

Scherl, Mark S. Silverberg, Ann Silverman, Stephan R. Targan, John F. Valentine, Ming-

Hsi Wang, Claire L. Simpson, S. Louis Bridges, Robert P. Kimberly, Stephen S. Rich,

Judy H. Cho, Anna Di Rienzo, Linda W. H. Kao, Dermot P. B. McGovern, Steven R.

Brant, and Subra Kugathasan. Characterization of Genetic Loci That Affect Susceptibility

to Inflammatory Bowel Diseases in African Americans. Gastroenterology

2015;149(6):1575–1586.

17. Brant, SR , Okou, D , Simpson, CL, Cutler, D, Haritunians, T, Bradfield, J, Chopra, P, Prince,

J, Begum, F, Kumar, A, Huang, C, Venkateswaran, S, Wei, Z , Thomas, KA, Herrinton, L,

Klapproth, JM , Quiros,A, Seminerio, J. Liu, J , Alexander, J , Baldassano, RN, Dudley-

Brown, S, Cross, R, Dassopoulos, T , Dhere, T, Dryden, G, Hanson,J, Hou, J, Hussain,S,

Denson, L, Hyams, J, Mack, D, Isaacs, K , Kader, H, Kappelman, H , Katz, J,

Kellermayer, R, Kirschner,B , Kuemmerle, J , Kwon. J, Li E. Mannon, P, Moulton, D,

Newberry,R, Osuntokun, B, Patel,A, Saeed,S, Targan,S, Valentine, J, Wang, MH

Lazarev, M, Zonca, M , Datta, L, Rioux, J, Duerr,R, Silverberg,M, Cho,J, Hakonarson,H,

Zwick,M and McGovern, D. Genome-wide Association Identifies African-Specific

Susceptibility Loci in African Americans with Inflammatory Bowel Disease.

(Gastroenterol. 2016 accepted)

18. Brant, SR, Paul, A, Kader, HA, Huang, C, DeRavin, SS and Malech, H. Genetic Risk for Inflammatory Bowel Disease is a Determinant of Crohn’s Disease Development in Chronic Granulomatous Disease. (Inflammatory Bowel Disease, 2016, accepted)

Non-peer reviewed journal articles:

1. Kader HA, Ing P, Buehler B, Sanger W. Cytogenetic confirmation of clinical diagnosis in

Nebraska. Nebr Med J 1990; 75(8):236-238.

2. McGowan KL, Kader HA. Clostridium difficile Infection in Children. Clinical Microbiology

Newsletter 1999; 21(7):49-53.

Book Chapters:

1. Kader HA, Liacouras CA. Abdominal Pain. In: Altschuler SM and Liacouras CA eds. Clinical

Pediatric Gastroenterology. Philadelphia; Churchill Livingstone, 1998, 5-8.

2. Jacobstein D, Kader HA, Antibiotic Therapy, In: Mamula P, Markowitz JE and Baldassano RN

eds. Pediatric Inflammatory Bowel Disease. New York; Springer Science+Business

Media, LLC, 2008, 329-336.

3. Contributing author, Kader HA, Transitions from Pediatric to Adult Healthcare Provider. In:

Oliva-Hemker M, Ziring D and Bousvaros A eds-in-chief. Your Child with Inflammatory

Bowel Disease: A Family Guide for Caregiving. Baltimore; The Johns Hopkins University

Press, 2010, 232-235.

4. Kader HA, Jacobstein D, Paul A. Chapter 27 Antibiotic Therapy, In: Mamula P, Markowitz JE

and Baldassano RN eds. Pediatric Inflammatory Bowel Disease. 2nd Ed.New York;

Springer Science+Business Media, LLC, 2013.

5. Kader HA, Paul A, Albenberg, L. Chapter 27 Antibiotic Therapy, In: Kelsen, AB and Judith R eds. Pediatric Inflammatory Bowel Disease. 3rd Ed.New York; Springer Science+Business Media, LLC, (in process)

Abstracts and/or Proceedings:

1. Kader HA, Sanger W, Fordyce R. Cytogenetic confirmation of clinical diagnosis in the Nebraska

area. Karyogram: J Cytogenetic Tech 1988; 14(4):70.

(Presented, Association of Cytogenetic Technologists, August, 1988, Kingston, Ontario,

Canada.)

2. Heck D, Sanger W, Severa S, Kader H. Establishment of breakage frequency in lymphocyte

cultures induced by Fragile X media. Karyogram: J Cytogenetic Tech 1988; 14(4):69.

(Presented, Association of Cytogenetic Technologists, August, 1988, Kingston, Ontario,

Canada.)

3. Severa S, Sanger W, Heck D, Kader H. Establishment of breakage frequency in lymphocyte

cultures induced by actinomycin-D. Karyogram: J Cytogenetic Tech 1988; 14(4):75-76.

(Presented, Association of Cytogenetic Technologists, August, 1988, Kingston, Ontario,

Canada.)

4. Kader HA, Kaufman SS, Vanderhoof JA, Young R, Raynor SC, Ruby EI, Mack DR.

Introduction of 6-mercaptopurine in Crohn’s disease patients during the perioperative

period. J Pediatr Gastroenterol Nutr 1996; 23(3):365.

(Presented, North American Society for Pediatric Gastroenterology & Nutrition, October,

1996, Denver, Colorado)

5. Kader HA, Piccoli DA, Jawad AF, McGowan KL, Maller ES. Clostridium difficile toxins A

and B in symptomatic patients at a tertiary pediatric hospital. Gastroenterology 1998;

A21:G0085.

(Presented, American Gastroenterological Association, May, 1998, New Orleans, LA)

6. Kader HA, Piccoli DA, Jawad AF, McGowan KL, Maller ES. The frequency of detection of

Clostridium difficile toxins A and B in symptomatic pediatric patients.

(Presented, European Society for Pediatric Gastroenterology and Nutrition/North American

Society for Pediatric Gastroenterology & Nutrition, May, 1998, Toulouse, France)

7. Kader HA, Gallagher PR, Baldassano RN. Experiences of immunomodulator (6-

mercaptopurine/azathioprine) therapy in severe pediatric ulcerative colitis.

(Presented, European Society for Pediatric Gastroenterology and Nutrition/North American

Society for Pediatric Gastroenterology & Nutrition, May, 1998, Toulouse, France)

8. Kader HA, Mascarhenas MR, Verma R, O’Connell BA, Collins MH, Baldassano RN.

Relationship between colitis and juvenile retention polyps in pediatric patients. J Pediatr

Gastroenterol Nutr 1998; 27(4):488.

(Presented, North American Society for Pediatric Gastroenterology and Nutrition, October,

1998, Orlanda, Florida)

9. Kader HA, Telega GW, Rand EB, Maller ES, Baldassano RN. Association of thiopurine

methyltransferase enzyme level with toxicity of 6-mercaptopurine/azathioprine in

pediatric patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1998;

27(4):472.

(Presented, North American Society for Pediatric Gastroenterology and Nutrition,

October, 1998, Orlanda, Florida)

10. Kader HA, Bellah RD, Mamula P, Loomes KM, Sentongo TS, Markowitz JE, Graham, KS,

Piccoli DA, Wenner WJ. The utility of ultrasound site selection for pediatric

percutaneous liver biopsy. Gastroenterology 1999; 116(4) Part 2: A68:G0290.

(Presented, American Gastroenterological Association, May, 1999, Orlando, Florida)

11. Kader HA, Theoret Y, Tolia V, Liacouras CA, Piccoli DA, Baldassano RN. A prospective

randomized double blind placebo controlled study to assess the efficacy of intravenous

loading of azathioprine in children and adolescents with inflammatory bowel disease.

(Presented, American Gastroenterological Association, May 2000, San

Diego, California)

12. Kader HA, Berman WF, Al-Seraihy AS, Ware RE, Ulshen MH, Treem WR. Prevalence of

Factor V G1691A (Leiden), Prothrombin G20210A, and Methylenetetrahydrofolate

Reductase C677T Thrombophilic Mutations in children with inflammatory bowel disease. J

Pediatr Gastroenterol Nutr 2001; 33(3):371-372.

(Presented, North American Society for Pediatric Gastroenterology and Nutrition,

October, 2001, Orlanda, Florida)

13. Kader HA, Tchernev VT, Satyaraj E, Lejnine S, Kotler G, Kingsmore SF, Patel DD. Protein

Microarray Analysis of Disease Activity in Pediatric Crohn’s Disease and Ulcerative colitis. J

Pediatr Gastroenterol Nutr 2003; 37(3):379.

(Presented, North American Society for Pediatric Gastroenterology and Nutrition,

October, 2003, Montreal, Quebec, Canada)

14. Katz MH, Murthy K, Kader HA, Halpin GJ, Tuchman DN. Diagnostic Lag Time in Pediatric

Patients with Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2003; 37(3):377.

(Presented, North American Society for Pediatric Gastroenterology and Nutrition,

October, 2003, Montreal, Quebec, Canada)

15. Okazaki, T, Kader HA, Isaacs, KL, Smoot DT, Lewis JD, Canakis J, Harris ML, Dassopoulos

T, Cho JH, Shugart YY, Brant, S. Evaluation of Sic22a4 and Sic22a5 IBD5 Locus

Functional Variants in African American IBD Patients and Controls. Gastroenterology

Suppl 2 2006; 130(4):T2009,A-593.

(Presented, American Gastroenterological Association, May 2006, Los Angeles)

16. Figueroa, BL, Reichard, KW MD, Halpin, G, Markowitz, J, Tuchman, DN, Murthy, K,

Jacobstein,D, Kader, HA. A Single Center Retrospective Study on the Post-Operative

Use of 6-mercaptopurine and/or Infliximab for Pediatric Patients with Crohn’s Disease. J

Pediatr Gastroenterol Nutr 2006; 43(4):E46. (Presented, North American Society for Pediatric Gastroenterology and Nutrition, October 2006, Orlanda, FL)

17. Kader, HA, Fassano A, Martin, M, Binnie, E, Jinadu, L. Early Onset Nephrotic Syndrome

in Pediatric Celiac Disease. (Presented, North American Society for Pediatric

Gastroenterology and Nutrition, October 2010, New Orleans, LA)

18. B. Boyle, W. Crandall, Nationwide Childrens Hospital, Columbus , OH; R. Colletti, M.

Qureshi, R. Baldassano, D. Milov, P. Margolis, A. Bousvaros, K. Crissinger, M. D'Amico,

A. Day, L. Denson, M. Dubinsky, D. Ebach, E. Hoffenberg, H. Kader, D. Keljo, I.

Leibowitz, P. Mamula, M. Pfefferkorn, PIBDNet Cohort Study Investigators, Burlington, VT; M. Kappelman, , UNC, Chapel Hill, NC. Clinical effectiveness of thiopurines in maintaining remission for pediatric Crohn’s disease. (Presented, North American Society for Pediatric Gastroenterology and Nutrition, October 2010, New Orleans, LA)

19. C. Huang, S.E. Ellis, B. Kuhr, K.L. Isaacs, A.L. Silverman, J.D. Lewis, D.T. Smoot, J.F.

Valentine, H.A. Kader, J.H. Cho, R.H. Duerr, J.D. Rioux, M. Silverberg, K.D. Taylor, Y.

Wu, S. Hooker, R.A. Kittles, L.W. Datta, S.R. Brant, NIDDK IBD Genetics Consortium

FCGR2A is the first Ulcerative Colitis susceptibility gene in African Americans;

(708W, p109) Presented, 12th International Congress of Human Genetics and the

American Society of Human Genetics 61st Annual Meeting, October 2011, Montreal,

Quebec, Canada)

20. Paul A, Blanchard S, Voigt, R, Kader, HA. Volvulus due to Constipation Necessitating Bowel

Resection.(Presented, North American Society for Pediatric Gastroenterology and Nutrition,

Annual Meeting October 2012, Salt Lake City, UT)



21. Rawal N, Malkani A, Safta A, Kader H, Zawahir S, Blanchard S. “A systematic review on

gluten and casein free diets in children with Autism: What do we know?” Presidential

Poster. Abstracts of the 78th Annual Scientific Meeting of the American College of

Gastroenterology. October 11-16, 2013. San Diego, California, USA.American, Journal of

Gastroenterology, Vol 108 , Suppl 1 , October 2013.

22. Booth JS, Toapanta FR, Salerno-Goncalves R, Patil s, Kader HA, Safta AM, Czinn SJ,

Greenwald BD, Sztein MB. Characterization of gastric tissue-resident memory CD8+ T

cells from children, adults and the elderly. (Presented, 9th European Mucosal

Immunology Group Meeting, Bute Hall, University of Glasgow, October 2014, Scotland,)

23. Rawal, N., Safta, A., Watkins, R., Zawahir, S., Malkani, A., Kader, H., Blanchard, S.

Treatment options for Nonalcoholic Fatty Liver Disease in children: A systematic review.

(Presented, American College of Gastroenterology, October 2014, Philadelphia, PA)

24. Rawal, N. Zawahir, S., Blanchard S., Kader, HA. The association of a thymic mass in a

pediatric patient with lymphocytic colitis. (Presented, North American Society for Pediatric

Gastroenterology and Nutrition, October 2014, Atlanta, GA)

25. Naguib, G, Shet N, Kaushal S, Pham P, Kader, HA. Dysphagia in an Atopic 8 year old: Not

Always Eosinophilic Esophagitis. (Presented, North American Society for Pediatric

Gastroenterology and Nutrition, October 2014, Atlanta, GA)

26. Booth JS, Toapanta FR, Salerno-Goncalves R, Patil s, Kader HA, Safta AM, Czinn SJ,

Greenwald BD, Sztein MB. Mucosal Associated Invariant T cells (MAIT) in the human

gastric mucosa and blood: Role in Helicobacter pylori infection. (Presented, 17th

International Congress of Mucosal Immunology, July 2015, Berlin, Germany)

27. Bisappa, N, Malkani, A, Alaish, SM, Medina de Jesus, A, Kader, HA. The Efficacy of an

Interdisciplinary Approach to Manage Pediatric Patients with Short Bowel Syndrome.

(Accepted: American College of Gastroenterology 2016 Annual Scientific Meeting &

Postgraduate Course, October 2016, Las Vegas, NV)

28. Zabrowski, DR, Rosenthal, Geoffrey, Kader, HA. Peripheral Eosinophilia in Inflammatory Bowel

Disease Patients on Infliximab is Not Associated with Adverse Outcomes. (Accepted:

World Congress of Pediatric Gastroenterology, Hepatology and Nutrition, October 2016,

Montreal, Quebec)

29. Ezirkie, J, Malkani, A, Leonard Puppa, E, Kader H, Teshome, G, Closson F, Blanchard S.

Appropriate Evaluation of Constipation in the Pediatric ED. (Accepted: American

College of Gastroenterology 2016 Annual Scientific Meeting & Postgraduate Course,

October 2016, Las Vegas, NV)

Other Brief Communications:

1. Kader HA, Maller ES. Letter to the Editor, Perianal Presentation of Langerhans Cell

Histiocytosis in Children. J. Pediatr Gastroenterol Nutr 2005; 41(1):135.

MAJOR INVITED SPEECHES:

LOCAL:

Philadelphia Gastrointestinal Research Forum: 36th Annual Komarov Prize Competition:

“Clinical Application of the Detection of Clostridium difficile Toxins A and B in

Symptomatic Patients at a Tertiary Pediatric Hospital.” June, 1998.

North American Society for Pediatric Gastroenterology and Nutrition, Annual Meeting,

Orlanda, Florida

“Association of thiopurine methyltransferase enzyme level with toxicity of 6-

mercaptopurine/azathioprine in pediatric patients with inflammatory bowel

disease.” October, 1998.

Combined Children’s Hospital of Philadelphia and Hospital of the University of

Pennsylvania Gastroenterology Conferences: Case Presentations and Lectures.

7/24/96 “Meckel’s Diverticulum”

9/4/96 “Superior Mesenteric Artery Syndrome”

10/23/96 “Dysmotility in Esophageal Atresia and Tracheoesophageal

Fistula”

10/23/96 “Upper GI Tract Foreign Bodies”

12/11/96 “Thrombotic Disorders: Thromboembolic Disease In

Inflammatory Bowel Disease”

2/26/97 “Alpha-1 Antitrypsin Deficiency: Neonatal/Childhood

Manifestations”

7/16/97 “Mesenteric/Portal Vein Thrombosis”

10/8/97 “Choledochal Cyst”

12/10/97 “Pyloric Stenosis”

4/29/98 “Barrett’s Esophagus”

1/27/99 “Infant Inflammatory Bowel Disease”

REX Healthcare, Raleigh, NC; Pediatric Grand Rounds 8/11/99, “Gastrointestinal

Emergencies”

Southern Regional Area Health Education Center, Cape Fear Valley Medical Center,

Fayetteville, NC; Family Medicine Noon Lecture 1/12/2000, “Constipation and

Encopresis”

Duke University Medical Center, Durham, NC; Pediatric Research Seminar 10/16/2001,

“Prevalence of Factor V G1691A (Leiden), Prothrombin G20210A, and

Methylenetetrahydrofolate Reductase C677T Thrombophilic Mutations in children

with inflammatory bowel disease”

Duke University Medical Center, Durham, NC; Pediatric Grand Rounds

4/9/2002 “Eosinophilic Esophagitis: GERD, Protein Allergy or Both”

Dutch’s Daughter, Frederick, MD; Presentation for TAP Pharmaceuticals, Inc. & Abbott

Laboratories 10/17/2002 “Atypical Manifestations of GERD/Pediatric

Gastroesophageal Reflux Disease”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Grand Rounds

12/17/2002 “Pediatric Inflammatory Bowel Disease”

Morton’s of Chicago, Baltimore, MD; Presentation for TAP Pharmaceuticals, Inc. & Abbott

Laboratories 6/5/2003 “Latest Developments in Pediatric Gastroesophageal Reflux

Disease”

The Children’s Hospital at Sinai in Baltimore, Baltimore, MD; Pediatric Grand Rounds

1/10/2006 “Allergic Eosinophilic Esophagitis”

Ruth Chris Steak House, Pikesville, MD; Presentation for TAP Pharmaceuticals, Inc

6/6/2006 “Addressing the Burning Question of Pediatric GERD”

Ruth Chris Steak House, Pikesville, MD; Presentation for TAP Pharmaceuticals, Inc

6/18/2008 “Scientific Update on Pediatric GERD in Children and Adolescents Ages

1-17 Years”

The University of Maryland Hospital for Children, Baltimore, MD; Pediatric Grand Rounds

1/14/2010 “Pediatric Inflammatory Bowel Disease”

The University of Maryland Medical Center & CCFA; “Living Well with IBD: Pediatric and

Adolescent IBD”. 11/3/2010 Hunt Valley Marriott, Hunt Valley, MD

Mercy Medical Center, Baltimore, MD; Pediatric Grand Rounds 2/4/2011 ”Pediatric

Inflammatory Bowel Disease.”

The University of Maryland Hospital for Children, Baltimore, MD; Pediatric Noon Lecture

10/14/2013 “Diagnosis and Management of Gastroesophageal Reflux Disease in

Pediatric Patients”

University of Maryland Children’s Hospital and the Crohn’s & Colitis Foundation of America

2013 Pediatric Inflammatory Bowel Disease (IBD) Patient & Family Education

Symposium with an IBD Health Expo. Moderator of the Symposium. Coppermine

Du Burns Arena, Baltimore, MD. October 20, 2013

NATIONAL:

Delaware Pharmacologist Society Annual Meeting, Dover, Delaware, 10/8/2004,

“Pediatric Acid Related Disorders: Strategies and Treatment”

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download